亚洲国产一区二区波多野结衣,久久精品综合福利免费视频,超碰中文字幕,欧美视频一区二区在线观看,国产欧美精品一区二区,一区二区三区视频免费观看,亚洲欧美一区二区三区久久,91亚洲精品一区二区乱,国产精品VA在线播放,久久免费人成网站福利院

Mitral regurgitation (MR) is a common cardiac valve lesion, developing from primary lesions of the mitral valve or secondary to cardiomyopathies. Moderate or higher severity of mitral regurgitation imposes significant volume overload on the left ventricle, causing permanent structural and functional deterioration of the myocardium and heart failure. Since correction of mitral regurgitation can provide symptomatic relief and halt progressive cardiac dysfunction, transcatheter mitral valve repair technologies are emerging as alternative therapies.

Enlight medical is developing transcatheter mitral valve repair and replacement devices, and its repair device NovoClasp^TM is now in the pivotal clinical study in China.